HIV Disclosure and Medication Adherence, a Pilot Study (RSAD-VIH-11)

December 21, 2015 updated by: Marie Schneider, Center for Primary Care and Public Health (Unisante), University of Lausanne, Switzerland
The investigators believe that disclosure of HIV status could influence medication adherence. If disclosure leads to social support, adherence could be improved. This study purpose is to assess correlation between disclosure and medication adherence, and to describe people whose HIV status has been disclosed to.

Study Overview

Status

Completed

Conditions

Detailed Description

Pharmacists administer a questionnaire to each consecutive subject taking part in the adherence-enhancing program at the pharmacy of the Department of Ambulatory Care And Community Medicine in Lausanne. This questionnaire assesses disclosure, response to disclosure, and living situation.

Adherence is measured by electronic monitoring and pill count.

Study Type

Observational

Enrollment (Anticipated)

120

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Switzerland
    • Vaud
      • Lausanne, Vaud, Switzerland, 1011
        • Policlinique Medicale Universitaire

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Patients enrolled in the adherence-enhancing program at ther pharmacy of Department of Ambulatory Care and Community Medicine in Lausanne

Description

Inclusion Criteria:

  • HIV Infection
  • Enrolled in the adherence-enhancing program

Exclusion Criteria:

  • Inclusion visit
  • Not french or english speaker

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Patient Adherence
Time Frame: 30 days before survey
Electronic monitoring of adherence during 30 days before survey
30 days before survey

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Patient Adherence
Time Frame: 90 days before survey
Electronic monitoring of adherence during 90 days before survey
90 days before survey

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Center for Primary Care and Public Health (Unisante), University of Lausanne, Switzerland

Collaborators

Centre Hospitalier Universitaire Vaudois
Swiss HIV Cohort Study

Investigators

  • Principal Investigator: Aurélie Gertsch, PhD-Student, Center for Primary Care and Public Health (Unisante), University of Lausanne, Switzerland
  • Study Chair: Olivier Bugnon, Professor, Center for Primary Care and Public Health (Unisante), University of Lausanne, Switzerland
  • Principal Investigator: Marie-Paule Schneider, PhD, Center for Primary Care and Public Health (Unisante), University of Lausanne, Switzerland
  • Study Chair: Matthias Cavassini, MD, Centre Hospitalier Universitaire Vaudois

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

April 1, 2012

Primary Completion (Actual)

June 1, 2013

Study Completion (Actual)

June 1, 2013

Study Registration Dates

First Submitted

May 31, 2012

First Submitted That Met QC Criteria

June 13, 2012

First Posted (Estimate)

June 18, 2012

Study Record Updates

Last Update Posted (Estimate)

December 22, 2015

Last Update Submitted That Met QC Criteria

December 21, 2015

Last Verified

December 1, 2015

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • RSAD-VIH-2011

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on HIV Infection

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Switzerland

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe